Prostate Cancer Market Set for Rapid Growth: Innovative Treatments and Rising Awareness Drive Global Demand 2025 | Top key players - Johnson & Johnson, Bayer AG, Novartis.

Market Size and Growth:

The Global Prostate Cancer Market size reached USD 11.7 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 21.6 billion by 2031. The prostate cancer market is expected to exhibit a CAGR of 8.1% from 2024-2031.

Prostate Cancer Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/prostate-cancer-market?sz

The Prostate Cancer Market refers to the global industry involved in the diagnosis, treatment, and management of prostate cancer. It encompasses pharmaceuticals, surgical interventions, radiation therapies, diagnostic tools, and emerging biologics. Driven by rising prevalence, technological advancements, and increased awareness, the market caters to patients, healthcare providers, and research institutions aiming to improve early detection, treatment outcomes, and quality of life.

Industry News of USA and Japan:

USA:

August 29, 2025: FDA approved a new 3-month, long-acting injectable formulation of leuprolide mesylate (Camcevi) for advanced prostate cancer.

August 13, 2025: FDA granted de novo authorization to ArteraAI Prostate, an AI-powered risk stratification tool for non-metastatic prostate cancer.

Japan:

Japan's prostate cancer therapy market is growing with increased focus on early detection, personalized medicine, and biomarker testing, with more than 50 new collaborations formed in 2023 to enhance market reach.

Major Japanese pharmaceutical companies are investing in next-generation therapies like PARP inhibitors and immunotherapies, backed by government support for accessibility and cancer research.

Key Players:

Johnson & Johnson
Astella, Inc.
Sanofi Aventis
IPSEN
Bayer AG
AstraZeneca
Valent Pharmaceuticals LLC
Sanofi-Aventis
Pfizer Inc.
Novartis International AG.

Growth Forecast Projected:

The Global Prostate Cancer Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Prostate Cancer Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=prostate-cancer-market

Market Segmentation:

By Therapy Type: Hormone therapy, Chemotherapy, Immunotherapy, Radiation, Focal therapies, Cryosurgery, High-intensity focused ultrasound.

By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/prostate-cancer-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Prostate Cancer market?

➠ Who are the leading manufacturers in the global Prostate Cancer industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Prostate Cancer industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Prostate Cancer market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.